(PharmaNewsWire.Com, July 20, 2024 ) North America was expected to dominate the market followed by Europe, in 2023 and it is expected to continue during the forecast period. Many key players in North America are working to improve the costly and time-consuming drug discovery process by innovating and adopting organ-on-chip technologies. Significant investments are being made by public and private institutions for research purposes. For Example: The Wyss Institute received nearly USD 5.6 million in grant money from the US FDA to Use its organ-on-chip technology to test human physiological responses to radiation as well as to assess drugs designed to counter radiation effects.
The Organ-On-Chip Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
Global Organ-On-Chip Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Organ-On-Chip Market are also profiled.
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
